Want to join the conversation?
$ALXN 2Q15 Call: Expects 3Q15 total revenues to be in the range of $662-665MM, including a continued negative currency impact of approx. $43-46MM as compared to 3Q14. On a sequential basis, 3Q15 revenue guidance includes a $4-6MM negative currency impact over 2Q15. 3Q15 results will include a full quarter of costs related to Synageva operations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?